Sign In
12 Aug 2013 07:00
DTR3
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/ PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS
All relevant boxes should be completed in block capital letters.
1. | Name of the issuer
ReNeuron Group plc | 2. | State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.2R; or (ii) a disclosure made in accordance with LR 9.8.6R(1); or (iii) in accordance with section 793 of the Companies Act 2006
(i)
|
3. | Name of person discharging managerial responsibilities/director
Dr. Paul Harper | 4. | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person
Director named in 3.
|
5. | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest 1
Interest of person named in 3
| 6. | Description of shares (including class), debentures or derivatives or financial instruments relating to shares
Ordinary Shares
|
7. | Name of registered shareholders(s) and, if more than one, the number of shares held by each of them
Person named in 3
| 8. | State the nature of the transaction
Placing of Ordinary Shares |
9. | Number of shares, debentures or financial instruments relating to shares acquired
Acquisition of 200,000 Ordinary Shares | 10. | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
0.011%
|
11. | Number of shares, debentures or financial instruments relating to shares disposed
| 12. | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
|
13. | Price per share or value of transaction
2.5 pence per Ordinary Share
| 14. | Date and place of transaction
9 August 2013 |
15. | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
Dr. Paul Harper is interested in a total of 451,709 Ordinary Shares in the Company representing approximately 0.025% of issued Ordinary Shares.
| 16. | Date issuer informed of transaction
9 August 2013 |
If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes
17. | Date of grant
| 18. | Period during which or date on which it can be exercised
| |||||||||||||||||||||||||||
19. | Total amount paid (if any) for grant of the option | 20. | Description of shares or debentures involved (class and number)
| |||||||||||||||||||||||||||
21. | Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise
| 22. | Total number of shares or debentures over which options held following notification | |||||||||||||||||||||||||||
23. | Any additional information
See table of options held by Dr. Paul Harper below:
| 24. | Name of contact and telephone number for queries
Pat Huggins, Reneuron Group Plc +44 (0)1483 302560 |
Name of authorised official of issuer responsible for making notification:
Patrick Huggins, Head of Finance and Company Secretary
Date of notification: 9 August 2013
|
Follow the stocks
